OTC Markets OTCPK - Delayed Quote USD

Venus Medtech (Hangzhou) Inc. (VMTHF)

0.2871

0.0000

(0.00%)

At close: April 11 at 4:00:00 PM EDT

Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study

Venus Medtech (Hangzhou) Inc. (Venus Medtech, 02500.HK), a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced that its in-house developed next-generation balloon-expandable dry-tissue transcatheter aortic valve replacement (TAVR) system, Venus-Vitae, successfully completed two inaugural implantations as part of its global multicenter pivotal trial, Venus-Vitae SMART-ALIGN, at Prince of Wales Hospital in Hong Kong, China.

PR Newswire 7 months ago

VMTHF
0.00%
Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.

Venus Medtech (02500. HK), a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced today that its in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, VenusP-Valve, has completed its first implantation in the PROTEUS IDE Pivotal Clinical Study at the University of Virginia School of Medicine. This momentous procedure was performed by a multidisciplinary team coordinated by Prof. Scott Lim and Prof. Mich

CNW Group 9 months ago

VMTHF
0.00%

Performance Overview

Return	VMTHF	HANG SENG INDEX (^HSI)
YTD	+2,558.33%	+4.26%
1-Year	+2,558.33%	+22.34%
3-Year	-93.24%	-1.38%

Try again.